https://www.selleckchem.com/pr....oducts/thiomyristoyl
6 ± 0.5 and 16.8 ± 0.4 years, respectively. At 6-months' follow-up, the GI was comparable among patients in the test- and control-group. In the test-group, the CFU/ml of oral yeasts were significantly higher at baseline compared with 6-months' follow-up (P less then 0.05). In the control-group, there was no statistically significant difference in the CFU/ml of oral yeasts at baseline and 6-months' follow-up. CONCLUSION The aPDT is a useful adjuvant to MD in reducing whole salivary oral yeasts counts among adolescents undergoing
Like
Comment
Share
